Grifols, S.A. (GRFS)
NASDAQ: GRFS · Real-Time Price · USD
7.28
-0.12 (-1.62%)
Jun 22, 2026, 4:00 PM EDT - Market closed
Grifols Revenue
Grifols had revenue of 1.70B EUR in the quarter ending March 31, 2026, a decrease of -4.82%. This brings the company's revenue in the last twelve months to 7.44B, up 0.89% year-over-year. In the year 2025, Grifols had annual revenue of 7.52M with 4.33% growth.
Revenue (ttm)
7.44B EUR
Revenue Growth
+0.89%
P/S Ratio
0.73
Revenue / Employee
294,625 EUR
Employees
25,247
Market Cap
6.28B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.52M | 312.00K | 4.33% |
| Dec 31, 2024 | 7.21M | 620.00K | 9.41% |
| Dec 31, 2023 | 6.59M | -6.06B | -99.89% |
| Dec 31, 2022 | 6.06B | 1.13B | 22.92% |
| Dec 31, 2021 | 4.93B | -406.92M | -7.62% |
| Dec 31, 2020 | 5.34B | 241.35M | 4.73% |
| Dec 31, 2019 | 5.10B | 611.97M | 13.64% |
| Dec 31, 2018 | 4.49B | 168.65M | 3.91% |
| Dec 31, 2017 | 4.32B | 268.24M | 6.62% |
| Dec 31, 2016 | 4.05B | 115.27M | 2.93% |
| Dec 31, 2015 | 3.93B | 579.18M | 17.26% |
| Dec 31, 2014 | 3.36B | 613.65M | 22.38% |
| Dec 31, 2013 | 2.74B | 120.79M | 4.61% |
| Dec 31, 2012 | 2.62B | 825.33M | 45.96% |
| Dec 31, 2011 | 1.80B | 804.88M | 81.24% |
| Dec 31, 2010 | 990.73M | 77.54M | 8.49% |
| Dec 31, 2009 | 913.19M | 98.88M | 12.14% |
| Dec 31, 2008 | 814.31M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pfizer | 63.32B |
| Novartis AG | 56.58B |
| Sanofi | 54.60B |
| Novo Nordisk | 50.57B |
| Bristol-Myers Squibb Company | 48.48B |
| GSK plc | 43.29B |
| Amgen | 37.22B |
| Gilead Sciences | 29.74B |
GRFS News
- 7 days ago - Grifols Launches Fesilty (GRFS) in the U.S. Market - GuruFocus
- 7 days ago - Grifols announces U.S. launch of new fibrinogen concentrate - TheFly
- 7 days ago - Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S. - GlobeNewsWire
- 5 weeks ago - Grifols price target lowered to EUR 10 from EUR 11 at Deutsche Bank - TheFly
- 6 weeks ago - Grifols reports Q1 adjusted EBITDA EUR 381M, up 0.8% cc - TheFly
- 6 weeks ago - Grifols says Q1 results support FY26 guidance - TheFly
- 2 months ago - New conditions imposed on Grifols by Health Canada, CBC News reports - TheFly
- 3 months ago - Ban Grifols and return plasma collection to Canadian Blood Services and Héma-Québec, say health care advocates - GlobeNewsWire